News | Breast Imaging | March 28, 2016

Company cites Volpara’s enhanced quantitative analytics capabilities as major growth drivers in breast density assessment market

Frost & Sullivan, Volpara Solutions, 2016 award, breast density

March 28, 2016 — Based on its recent analysis of the breast density assessment solutions market, Frost & Sullivan recognizes Volpara Solutions with the 2016 Global Frost & Sullivan Award for Competitive Strategy Innovation and Leadership.

Volpara Solutions offers a suite of multi-vendor breast imaging tools including VolparaDensity, VolparaAnalytics, VolparaDose, and VolparaResearch. The quantitative software tools allow for personalized measurements of volumetric breast density, patient dose, breast compression and other factors designed to help maintain accuracy and consistent quality in breast screening.

VolparaAnalytics provides quality metrics and key performance indicators that let facilities evaluate their mammography and tomosynthesis system utilization, examination times, patient dose, patient positioning and patient comfort. This can help sites correct issues that may impact the quality of the breast imaging services they deliver and help improve quality of care.

"The company believes that the more specific data it provides to the medical professional, the more it contributes to securing an accurate diagnosis for patients, and this is a driving force behind new solution developments that collect a new type of data," said Frost & Sullivan's Research Associate, Svetlana Korosteleva. "Volpara Solutions leverages modern network technologies and supporting IT [information technology] deployment models. It intends to further expand its analytics capabilities by leveraging wider sets of metrics that enable it to switch to predictive healthcare, the next frontier for the healthcare industry."

Frost & Sullivan is pleased to recognize Volpara Solutions for innovative strategies in strengthening its brand and thereby, demand for its products, in the intensely competitive breast density assessment solutions market.

Each year, Frost & Sullivan presents this award to the company that has leveraged competitive intelligence to successfully execute a competitive strategy that results in stronger market share, competitive brand positioning and customer satisfaction.

For more information: www.volparasolutions.com


Related Content

News | PET Imaging

May 30, 2025 — GE HealthCare recently announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) ...

Time May 30, 2025
arrow
News | Imaging Software Development

May 27, 2025 — DeepLook Medical, a company advancing medical imaging through visual enhancement technology, recently ...

Time May 28, 2025
arrow
News | Breast Imaging

May 13, 2025 — In one of the larger studies of its kind, researchers have identified six breast texture patterns that ...

Time May 16, 2025
arrow
News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Breast Imaging

March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound ...

Time March 21, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Breast Imaging

March 04, 2025 — Optellum has entered a strategic agreement with Volpara Health, a Lunit company and a provider of ...

Time March 04, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
Subscribe Now